Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
Lilly has launched a single-dose vial model of Zepbound (tirzepatide) for self-pay sufferers. The one-dose is out there in 2.5 mg and 5 mg doses. Zepbound is used to deal with adults who’re overweight as measured by physique mass index or those that are chubby and have hypertension, diabetes, or excessive ldl cholesterol. Tirzepatide can … Read more